Special Issue "Medical Complications and Supportive Care in Patients with Cancer"
Deadline for manuscript submissions: 30 June 2024 | Viewed by 3970
Interests: cancer; oncological emergencies; supportive care; autoimmune diseases; infectious diseases; critical care; vasculitis; immunotherapy; immune-related adverse events
Special Issues, Collections and Topics in MDPI journals
The prevalence of cancer is increasing due to the aging population, early diagnosis and the therapeutic novelties that have appeared in recent years (targeted therapies or different modalities of immunotherapy, among others) and have led to improvements in the survival of patients with oncological diseases. However, this has also caused an increase in the complexity in the management of these patients, who present classic complications of cancer (oncological emergencies, thromboembolic disease or infectious diseases) but also pose new challenges for the professionals who provide them with medical care (new treatment toxicities such as immune-related adverse events, the adverse effects of CAR-T cell therapies or the need for intensive care). In addition, other challenges arise in parallel: older patients may be candidates for oncologic treatment (oncogeriatrics), and the palliative needs of patients are becoming more complex and require specialized attention.
For all these reasons, we believe that this Special Issue will be of great interest to professionals who work with cancer patients and strive to provide the best care for those experiencing medical complications of cancer and receiving supportive or palliative care. Papers related to these areas are welcome to be submitted to this Special Issue, whether they are about oncological emergencies, infectious diseases in cancer patients, treatment toxicities, immune-related adverse events, supportive care, palliative care or thromboembolic disease, among others.
Dr. Javier Marco-Hernández
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- oncological emergencies
- immune-related adverse events
- supportive care
- palliative care
- infectious diseases
- thromboembolic disease
- treatment toxicities
- CAR-T cell therapy